Eris Biotech
Y Combinator
ONCOLOGY
DRUG-DISCOVERY
BIOTECH
THERAPEUTICS
Current Round
Pre Seed
About
Our drugs engage the immune system to fight tumors
Prediction Markets
Would Eris Biotech have an exit before end of 2030?
62% YES
Closes: Dec. 31, 2030
Would Eris Biotech get next round of funding before end of 2025?
62% YES
Closes: Dec. 31, 2025